These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25051708)

  • 81. The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin.
    Kim YI; Pareek R; Murphy R; Harrison L; Farrell E; Cook R; DeVincenzo J
    Influenza Other Respir Viruses; 2017 Nov; 11(6):525-530. PubMed ID: 28990339
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [The effect of exogenous interferon on the reproduction of the viruses of Russian tick-borne encephalitis and western equine encephalomyelitis in cell cultures].
    Grokhovskaia AA
    Vopr Virusol; 1966; 11(2):163-6. PubMed ID: 6002455
    [No Abstract]   [Full Text] [Related]  

  • 83. Non-viraemic transmission of tick-borne viruses.
    Havlíková S; Ličková M; Klempa B
    Acta Virol; 2013; 57(2):123-9. PubMed ID: 23600870
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Reproduction of tick-borne encephalitis virus and inhibition of formation and action of interferon in the presence of deuterium oxide.
    Mayer V; Dobrocká E
    Acta Virol; 1968 May; 12(3):247-56. PubMed ID: 4385156
    [No Abstract]   [Full Text] [Related]  

  • 85. [The reproduction of the tick-borne encephalitis virus in human leukocytes].
    Leonova GN; Timofeev IV; Orlova TG
    Vopr Virusol; 1991; 36(1):61-3. PubMed ID: 1858359
    [No Abstract]   [Full Text] [Related]  

  • 86. [Triazavirin prophylactic efficacy against influenza virus A (H5N1)].
    Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP; Kotovskaia SK; Rusinov VL; Charushin VN; Chupakhin ON
    Antibiot Khimioter; 2010; 55(9-10):25-8. PubMed ID: 21400750
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Properties of transfected strains of tick-borne encephalitis virus.
    Gavrilov VI; Bogomolova NN; Deryabin PG; Astakhova AV; Andzhaparidze OG; Zhidanov VM
    Arch Gesamte Virusforsch; 1974; 46(3-4):248-52. PubMed ID: 4615651
    [No Abstract]   [Full Text] [Related]  

  • 88. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.
    Jordan I; Briese T; Fischer N; Lau JY; Lipkin WI
    J Infect Dis; 2000 Oct; 182(4):1214-7. PubMed ID: 10979920
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Synthesis and antiviral activity of azoles obtained from carbohydrates.
    Barradas JS; Errea MI; D'Accorso NB; Sepúlveda CS; Talarico LB; Damonte EB
    Carbohydr Res; 2008 Sep; 343(14):2468-74. PubMed ID: 18692179
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Influence of tick-borne encephalitis and West Nile viruses on the chromosomes of pig kidney cells.
    Varadinova T; Gresíkova M; Batíková M
    Acta Virol; 1983 May; 27(3):238-44. PubMed ID: 6138985
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Synthetic approaches to 1,2,4-triazolo[5,1-
    Artem'ev GA; Rusinov VL; Kopchuk DS; Savchuk MI; Santra S; Ulomsky EN; Zyryanov GV; Majee A; Du W; Charushin VN; Chupakhin ОN
    Org Biomol Chem; 2022 Mar; 20(9):1828-1837. PubMed ID: 35137762
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [A new antiviral drug Triazavirin: results of phase II clinical trial].
    Kiselev OI; Deeva EG; Mel'nikova TI; Kozeletskaia KN; Kiselev AS; Rusinov VL; Charushin VN; Chupakhin ON
    Vopr Virusol; 2012; 57(6):9-12. PubMed ID: 23477247
    [TBL] [Abstract][Full Text] [Related]  

  • 93. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery.
    Kumar S; Basu M; Ghosh P; Pal U; Ghosh MK
    Genes Dis; 2023 Jul; 10(4):1402-1428. PubMed ID: 37334160
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Triazavirin-A Novel Effective Antiviral Drug.
    Chupakhin ON; Rusinov VL; Varaksin MV; Ulomskiy EN; Savateev KV; Butorin II; Du W; Sun Z; Charushin VN
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498864
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical features and mechanistic insights into drug repurposing for combating COVID-19.
    Asrani P; Tiwari K; Eapen MS; McAlinden KD; Haug G; Johansen MD; Hansbro PM; Flanagan KL; Hassan MI; Sohal SS
    Int J Biochem Cell Biol; 2022 Jan; 142():106114. PubMed ID: 34748991
    [TBL] [Abstract][Full Text] [Related]  

  • 96. COVID-19: Myths and Reality.
    Kordyukova LV; Shanko AV
    Biochemistry (Mosc); 2021 Jul; 86(7):800-817. PubMed ID: 34284707
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Potential drug development and therapeutic approaches for clinical intervention in COVID-19.
    Dowarah J; Marak BN; Yadav UCS; Singh VP
    Bioorg Chem; 2021 Sep; 114():105016. PubMed ID: 34144277
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial.
    Wu X; Yu K; Wang Y; Xu W; Ma H; Hou Y; Li Y; Cai B; Zhu L; Zhang M; Hu X; Gao J; Wang Y; Qin H; Wang W; Zhao M; Wu X; Zhang Y; Li L; Li K; Du Z; Mol BWJ; Yang B
    Engineering (Beijing); 2020 Oct; 6(10):1185-1191. PubMed ID: 32923016
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol.
    Wu X; Yu K; Wang Y; Xu W; Ma H; Hou Y; Li Y; Cai B; Zhu L; Zhang M; Hu X; Gao J; Wang Y; Qin H; Zhao M; Zhang Y; Li K; Du Z; Yang B
    Engineering (Beijing); 2020 Oct; 6(10):1199-1204. PubMed ID: 32837750
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Investigation of Triazavirin antiviral activity against tick-borne encephalitis pathogen in cell culture].
    Loginova SIa; Borisevich SV; Rusinov VL; Ulomskiĭ UN; Charushin VN; Chupakhin ON
    Antibiot Khimioter; 2014; 59(1-2):3-5. PubMed ID: 25051708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.